Compare CVS Health Corp (CVS) vs Plby Group Inc (PLBY) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
CVS Health Corp vs Plby Group Inc — how do they compare? CVS Health Corp trades at $86.01 (market cap $112.29B), while Plby Group Inc trades at $1 (market cap $118.21M). The key difference: CVS Health Corp is far larger — about 949.9× Plby Group Inc's market cap, and CVS Health Corp pays a 3.03% dividend while Plby Group Inc pays none. Which is the better fit depends on your goals — on Pluang, investors hold CVS Health Corp for 83 Days and Plby Group Inc for 24 Days on average.
| CVS | PLBY | |
|---|---|---|
Market Cap | $112.29B | $118.21M |
Volume | 7,763,676 | 919,783 |
Sector | Health | Consumer Cyclical |
52-Week High | $110.60 | $2.71 |
52-Week Low | $70.08 | $0.99 |
Typical Hold Time | 83 Days | 24 Days |
Enterprise Value | $174.64B | $263.80M |
Dividend Yield | 3.03% | — |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
CVS Health trades at $87.95, up 1.76% with strong analyst support (85% buy ratings) and a $111.20 consensus price target suggesting 26% upside. Recent quarterly earnings consistently beat expectations, with Q2 2026 EPS of $2.58 surpassing the $1.85 estimate. Revenue growth remains solid at $402.07 billion for 2025, though net margins compressed to 1.18%. Technical indicators show a bullish overall signal with support at $87 and resistance at $89.
The outlook remains positive given CVS's dominant market position and Medicare expansion plans, but investors face risks from reimbursement pressures and ongoing legal investigations. Earnings growth and successful execution of healthcare services integration represent the primary catalysts for continued stock appreciation.
PLBY Group trades at $1.02, down 1.92% on the day, with a bearish technical signal from moving averages. The company shows improving fundamentals with revenue stabilizing around $120-125 million and net losses narrowing significantly from -$278 million in 2022 to -$13 million in 2025. Recent management appointments aim to drive brand growth, while positive operating cash flow in 2025 and projected profitability in 2026 signal potential turnaround.
While analyst consensus remains strongly bullish (75% buy ratings), the stock faces headwinds from high debt levels and negative shareholder equity. The path to sustainable profitability remains the key catalyst, with current valuation metrics suggesting cautious optimism if execution improves. Near-term price action appears range-bound near support levels.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About CVS Health Corp
Following its acquisition of Aetna in late 2018, CVS Health now provides an even more integrated healthcare-services offering for its members. Legacy CVS combined both the largest pharmacy benefit manager, processing over 2 billion adjusted claims annually, and a sizable pharmacy operation, including nearly 10,000 retail pharmacy locations primarily in the U.S. Adding a managed-care organization with 24 million medical members gives the company a strong position in the insurance industry and should help CVS better control overall healthcare costs for its clients.
Read more on CVS →About Plby Group Inc
PLBY Group Inc is a pleasure and leisure company. The company's segment includes Licensing, Direct-to-Consumer, and Digital Subscriptions and Content. It generates maximum revenue from the Direct-to-Consumer segment. Direct-to-Consumer operations include consumer products sold through third-party retailers or online direct-to-customer. Geographically, it derives a majority of revenue from the United States.
Read more on PLBY →
